Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
175,611,455
-
Number of holders
-
425
-
Total 13F shares, excl. options
-
128,213,716
-
Shares change
-
+2,558,188
-
Total reported value, excl. options
-
$2,762,470,436
-
Value change
-
+$64,064,682
-
Put/Call ratio
-
59%
-
Number of buys
-
158
-
Number of sells
-
-215
-
Price
-
$21.55
Significant Holders of Teladoc Health, Inc. - Common Stock, par value $0.001 per share (TDOC) as of Q4 2023
530 filings reported holding TDOC - Teladoc Health, Inc. - Common Stock, par value $0.001 per share as of Q4 2023.
Teladoc Health, Inc. - Common Stock, par value $0.001 per share (TDOC) has 425 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 128,213,716 shares
of 175,611,455 outstanding shares and own 73% of the company stock.
Largest 10 shareholders include ARK Investment Management LLC (21,224,565 shares), VANGUARD GROUP INC (17,515,127 shares), BlackRock Inc. (13,141,478 shares), Sumitomo Mitsui Trust Holdings, Inc. (7,474,674 shares), Nikko Asset Management Americas, Inc. (7,464,874 shares), STATE STREET CORP (5,391,637 shares), RENAISSANCE TECHNOLOGIES LLC (4,875,184 shares), DIMENSIONAL FUND ADVISORS LP (3,834,422 shares), MORGAN STANLEY (3,186,475 shares), and GEODE CAPITAL MANAGEMENT, LLC (2,490,657 shares).
This table shows the top 425 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.